Mr. Adrian Cheng is the Chief Executive Officer of New World Development.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
EpimAb Biotherapeutics | 22-Mar-2021 | Later Stage VC | 00000 | Biotechnology | Clinical Trials - Phase 1 | |
000000 000000 | 10-Mar-2021 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - Phase 2 | |
000000000 | 26-Feb-2021 | 00000 00000 | 00000 | Biotechnology | Generating Revenue | |
00000 000000000000 | 09-Oct-2020 | 00000 00000 | 00000 | Biotechnology | Generating Revenue | |
00000 0000000000 | 18-Dec-2019 | 00000 00000 | Business/Productivity Software | Generating Revenue | 000000 00000 | |
000000 0000 | 16-May-2019 | 00000 000000 | Other Commercial Banks | Generating Revenue | 000000 00000 | |
00 00 0000 | 06-Sep-2018 | 00000 00000 | 000.00 | Application Software | Generating Revenue | 000000 00000 |
0000.00 | 11-Jul-2018 | 00000 00000 | 00000 | Automotive | Generating Revenue | 000000 00000 |
DayDayCook | 01-Jun-2018 | Early Stage VC | 000.00 | Food Products | Generating Revenue | 000000 00000 |
Xiaohongshu | 19-May-2018 | Later Stage VC | 00000 | Internet Retail | Generating Revenue |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Alphamab | 12-Dec-2019 | IPO | 00000 |
000 00000000 | 14-Sep-2018 | 000 | 00000 |
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialName | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Adrian Cheng | Angel Investor | 0 | Hong Kong, Hong Kong |
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
C Ventures | 2 | 0 |
![]() |
![]() |
|
Eight Roads | 0 | 0 |
![]() |
![]() |
|
Mirae Asset Global Investments | 0 | 0 |
![]() |
![]() |
|
Tencent Holdings | 0 |
![]() |
![]() |
||
ARCH Venture Partners | 0 | 0 |
![]() |
![]() |